TrialPloS one2021

Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial.

Carmen Hernandez-Cardenas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.